Peroxisome proliferator hepatocarcinogens lack genotoxic activity in numerous in vitro assays using non-target cells which do not respond with peroxisome proliferation. Therefore, the effect of in vivo treatment with WY-14,643 on DNA repair was quantitated in rat hepatocytes, the target cell for carcinogenesis. Palmitoyl CoA oxidase and carnitine acetyltransferase activities in isolated hepatocytes were elevated by WY-14,643 (50 mg/kg/day by gavage for up to 5 consecutive days) and by WY-14,643 (0.1%) or di(2-ethyl-hexyl)phthalate (DEHP) (1.2%) feeding (for up to 28 days), indicating peroxisome proliferation had occurred. DNA repair as unscheduled DNA synthesis (UDS) was measured autoradiographically as net nuclear grains following thymidine incorporation in primary hepatocyte cultures. Treatment of rats with WY-14,643 (gavage or feeding) or DEHP (feeding) did not induce UDS. Addition of 2-acetylaminofluorene to replicate cultures demonstrated that WY-14,643 or DEHP treatment did not prevent repair response. Additional cultures were treated with H2O2 (0.8 mM H2O2 3x at 1-h intervals) to evaluate the ability of UDS to detect any repair which may be induced by peroxisomal metabolism. H2O2 did not induce UDS at this concentration, nor did it prevent 2-acetylaminofluorene-induced repair. UDS was, however, observed in a separate experiment using a higher concentration of H2O2. In summary, a highly carcinogenic peroxisome proliferator did not induce UDS in the target cell for carcinogenesis in spite of peroxisome proliferation following in vivo treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/9.7.1179DOI Listing

Publication Analysis

Top Keywords

peroxisome proliferator
12
vivo treatment
12
peroxisome proliferation
12
induce uds
12
unscheduled dna
8
dna synthesis
8
rat hepatocytes
8
proliferation vivo
8
dna repair
8
target cell
8

Similar Publications

Effects of combined stressors to TCDD and high temperature on HSP/CYPs signaling in the zebrafish embryos/larvae.

Environ Pollut

March 2025

College of Animal Science and Technology, Inner Mongolia Minzu University, Tongliao, Inner Mongolia, 028000, China; Inner Mongolia Key Laboratory of Toxicant Monitoring and Toxicology. Electronic address:

Global warming causes the release of dioxin-like deposits and increases geographical migration, increasing the risk of exposure for humans and animals. In this experiment, we used CYP1A transgenic zebrafish Tg (cyp1a: mCherry) and liver fluorescent transgenic zebrafish Tg (fabp10: Ps Red) as an animal model and exposed to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) at 26 °C and 30 °C, respectively. Morphological changes, histological changes, transcriptome and related genes expression were detected.

View Article and Find Full Text PDF

Insulin resistance (IR) disrupts hepatic glucose metabolism and mitochondrial function, which contributes to metabolic disorders. The present study examined the effects of tomatine on glucose metabolism in high-glucose-induced IR hepatocytes and explored its underlying mechanisms using AML12 and HepG2 cell models. The results showed that tomatine did not exhibit cytotoxic effects.

View Article and Find Full Text PDF

infects the placenta of its natural bovine host, which results in abortion and transmission of infection to other cattle and to humans. While the metabolism of during chronic infection of the mononuclear phagocyte system has been studied, the nutrients fueling growth of in the placenta are unknown. We found that in mice, glucose is an important carbon source for in the placenta.

View Article and Find Full Text PDF

Seladelpar for the Treatment of Primary Biliary Cholangitis.

Ann Pharmacother

March 2025

Department of Pharmacy Education and Practice, College of Pharmacy, University of Florida, Gainesville, FL, USA.

Objective: To review the published data including the pharmacology, efficacy, and safety of seladelpar, a peroxisome proliferator-activated receptor delta (PPARδ) agonist leading to the Food and Drug Administration (FDA) accelerated approval for the treatment of primary biliary cholangitis (PBC).

Data Sources: A PubMed (January 1, 1985 to January 27, 2025) literature search was performed using the terms seladelpar, MBX-8025, peroxisome proliferator-activated receptor agonist, and PBC. Other data sources included Google Scholar and the National Institutes of Health Clinical Trials Registry.

View Article and Find Full Text PDF

Therapeutic potential of elafibranor in alcohol-associated liver disease: Insights into macrophage modulation and fibrosis reduction.

World J Biol Chem

March 2025

Department of Biological Sciences and Chemistry, College of Arts and Sciences, University of Nizwa, Nizwa 616, Ad Dākhilīyah, Oman.

Alcohol-associated liver disease (ALD) is a major global health concern, contributing to liver injury, morbidity, and mortality. Elafibranor (EFN), a dual peroxisome proliferator-activated receptor α/δ agonist, has shown promise as a therapeutic candidate in preclinical studies. EFN reduces liver fibrosis by inhibiting lipid accumulation, apoptosis, and inflammatory pathways (LPS/TLR4/NF-κB), while enhancing autophagy and antioxidant responses.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!